- About us
- Brands
- Sustainability
- Investors
- Fiskars as an investment
- Financials
- Shares & shareholders
- Corporate Governance
- Reports & presentations
- IR calendar
- Investor relations
- Careers
- Media
- Contacts
2019 | 2018 | 2017 | 2016 | 2015 | ||
|
||||||
Net sales | EUR million | 1,090.4 | 1,118.5 | 1,185.5 | 1,204.6 | 1,107.1 |
of which outside Finland | EUR million | 977.5 | 1,006.6 | 1,073.1 | 1,102.0 | 849.4 |
in percent of net sales | % | 89.6 | 90.0 | 90.5 | 81.1 | 76.7 |
export from Finland | EUR million | 20.2 | 19.5 | 22.8 | 24.3 | 57.1 |
Percentage change of net sales | % | -2.5 | -5.6 | -1.6 | 8.8 | 44.3 |
|
||||||
Gross profit | EUR million | 447.3 | 485.1 | 512.2 | 502.9 | 420.2 |
in percent of net sales | % | 41.0 | 43.4 | 43.2 | 41.7 | 38.0 |
EBITA* | EUR million | 72.9 | 112.5 | 113.2 | 96.7 | 62.1 |
in percent of net sales | % | 6.7 | 10.1 | 9.5 | 8.0 | 5.6 |
|
||||||
Comparable EBITA* | EUR million | 90.6 | 122 | 119 | 107 | 75.7 |
|
||||||
Change in fair value of biological assets | EUR million | -0.2 | 2.0 | 0.7 | -0.5 | -0.2 |
Financial items net | EUR million | 3.4 | 9.4 | 119.3 | 10.5 | 79.3 |
in percent of net sales | % | 0.3 | 0.8 | 10.1 | 0.9 | 7.2 |
Profit before taxes | EUR million | 63.2 | 103.0 | 217.8 | 92.8 | 125.5 |
in percent of net sales | % | 5.8 | 9.2 | 18.4 | 7.7 | 11.3 |
Income tax | EUR million | -10.8 | 21.1 | -50.8 | -27.4 | -39.2 |
|
||||||
Profit for the period attributable to the equity holders of the company |
EUR million | 51.7 | 81.6 | 166.4 | 64.1 | 85.1 |
in percent of net sales | % | 4.7 | 7.3 | 14.0 | 5.3 | 7.7 |
Non-controlling interests' share of profit | EUR million | 0.7 | 0.2 | 0.7 | 1.3 | 1.2 |
|
||||||
Employee benefits | EUR million | 311.9 | 307.9 | 315.3 | 337.1 | 291.3 |
Depreciation, amortization and impairment | EUR million | 59.6 | 43.8 | 38.8 | 37.4 | 42.8 |
in percent of net sales | % | 5.5 | 3.9 | 3.3 | 3.1 | 3.9 |
Cash flow from operating activities | EUR million | 96.5 | 105.9 | 103.8 | 83.8 | 47.6 |
Capital expenditure | EUR million | 40.0 | 46.2 | 32.8 | 37.6 | 32.4 |
in percent of net sales | % | 3.7 | 4.1 | 2.8 | 3.1 | 2.9 |
Research and development costs in income statement | EUR million | 18.4 | 18.4 | 18.8 | 18.0 | 18.0 |
in percent of net sales | % | 1.7 | 1.6 | 1.6 | 1.5 | 1.6 |
Capitalized development costs | EUR million | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
|
||||||
Equity attributable to equity holders of the company | EUR million | 760.9 | 1,207.0 | 1,269.4 | 1,218.1 | 1,190.8 |
Non-controlling interest | EUR million | 3.6 | 2.7 | 2.8 | 1.9 | 3.3 |
Equity total | EUR million | 764.5 | 1,209.7 | 1,272.1 | 1,220.1 | 1,194.0 |
Net interest-bearing debt | EUR million | 261.1 | 135.4 | 147.7 | 152.4 | 249.4 |
Working capital | EUR million | 194.4 | 197.0 | 195.9 | 217.8 | 190.5 |
Balance sheet total | EUR million | 1,364.3 | 1,719.2 | 1,837.9 | 1,760.1 | 1,833.3 |
|
||||||
Return on investment | % | 6.0 | 7.9 | 15.4 | 6.8 | 8.4 |
Return on equity | % | 5.3 | 6.6 | 13.4 | 5.4 | 7.4 |
Equity ratio | % | 56.0 | 70.4 | 69.3 | 69.3 | 65.1 |
Net gearing | % | 34.2 | 11.2 | 11.6 | 12.5 | 20.9 |
|
||||||
Personnel (FTE), average | 6,840 | 7,304 | 7,709 | 8,000 | 6,303 | |
Personnel, end of period | 6,984 | 7,706 | 7,932 | 8,560 | 9,003 | |
of which outside Finland | 5,852 | 6,581 | 6,806 | 7,336 | 7,715 |